- Home
- ILMN vs ANSS Comparison
ILMN vs ANSS Comparison
Compare ILMN & ANSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- ANSS
- Stock Information
- Founded
- ILMN 1998
- ANSS 1970
- Country
- ILMN United States
- ANSS United States
- Employees
- ILMN N/A
- ANSS N/A
- Industry
- ILMN Medical Specialities
- ANSS Computer Software: Prepackaged Software
- Sector
- ILMN Health Care
- ANSS Technology
- Exchange
- ILMN Nasdaq
- ANSS Nasdaq
- Market Cap
- ILMN 22.9B
- ANSS 27.8B
- IPO Year
- ILMN 2000
- ANSS 1996
- Fundamental
- Price
- ILMN $140.54
- ANSS $341.99
- Analyst Decision
- ILMN Buy
- ANSS Hold
- Analyst Count
- ILMN 20
- ANSS 6
- Target Price
- ILMN $160.68
- ANSS $342.50
- AVG Volume (30 Days)
- ILMN 2.2M
- ANSS 529.1K
- Earning Date
- ILMN 11-04-2024
- ANSS 11-06-2024
- Dividend Yield
- ILMN N/A
- ANSS N/A
- EPS Growth
- ILMN N/A
- ANSS 17.14
- EPS
- ILMN N/A
- ANSS 6.48
- Revenue
- ILMN $4,390,000,000.00
- ANSS $2,467,743,000.00
- Revenue This Year
- ILMN N/A
- ANSS $13.17
- Revenue Next Year
- ILMN $4.28
- ANSS $9.54
- P/E Ratio
- ILMN N/A
- ANSS $55.63
- Revenue Growth
- ILMN N/A
- ANSS 14.30
- 52 Week Low
- ILMN $97.36
- ANSS $280.42
- 52 Week High
- ILMN $156.66
- ANSS $364.31
- Technical
- Relative Strength Index (RSI)
- ILMN 50.00
- ANSS 53.53
- Support Level
- ILMN $138.88
- ANSS $345.65
- Resistance Level
- ILMN $145.37
- ANSS $363.03
- Average True Range (ATR)
- ILMN 4.83
- ANSS 6.96
- MACD
- ILMN 0.13
- ANSS 0.08
- Stochastic Oscillator
- ILMN 77.38
- ANSS 49.10
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About ANSS ANSYS Inc.
Ansys is an engineering software company that provides simulation capabilities for structural, fluids, semiconductor power, embedded software, optical, and electromagnetic properties. Ansys employs over 4,000 people and serves over 50,000 customers globally, including those in aerospace defense and automotive.